Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Telbivudine+Adefovir in Lamivudine-Refractory HBV
NCT01270165Phase 3Unknown
- Sponsor
- Yonsei University
- Start
- Jun 2010
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Yonsei University. Status: unknown.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01270165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270165.